MIKALA HUGHES: Open Payments
NPI 1467059790 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 11 payments from 8 companies in 2025. Trend: 2023 $536 · 2024 $322 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Alkermes, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, Cologuard Collection Kit, CAPLYTA, FANAPT.
Industry payments across FL — which companies pay providers there.
